Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Accuracy and diagnostic value of outpatient hysteroscopy for malign and benign disease
1Department of Obstetrics, Women’s Diseases and Oncogynecology, Central Clinical Hospital of Ministry of Interior and Administration, Warsaw
2Center for Reproductive Health, Institute of Mother and Child’s Health, Warsaw (Poland)
*Corresponding Author(s): A.J. Jakimiuk E-mail: jakimiuk@yahoo.com
Background: The aim of the study was to evaluate accuracy of the outpatient hysteroscopy. Materials and Methods: This was a retrospective cohort study of 494 women who underwent outpatient hysteroscopy after administration of non-steroidal anti-inflammatory agents with the 3.2 mm hysteroscope. Normal saline solution was used as the distension medium. All women were discharged in good general condition afterwards. Results: In cases of abnormal uterine bleeding, there was no apparent pathology found in 112 cases (83.6%). Detection rate (DR) of endometrial polyps was 88.7% with false positive rate (FPR) of 4.6%. Positive predictive value (PPV) was 82.7% with negative predictive value (NPV) of 93.1%. Detection rate (DR) of the submucosal fibroids was 57.7%. Positive predictive value (PPV) was 57.7% with negative predictive value (NPV) of 95.0%. Endometrial cancer was confirmed in ten cases (2.0%), being suspected in eight cases during the procedure. DR in case of the endometrial cancer was 80.0% with FPR of 0.4%. PPV was 66.7% with NPV) of 99.6%. Conclusions: Outpatient hysteroscopy seems to be an effective and accurate diagnostic tool.
Office hysteroscopy; Outpatient hysteroscopy; Hysteroscopy.
T. Issat,J. Beta,M.A. Nowicka,A.J. Jakimiuk. Accuracy and diagnostic value of outpatient hysteroscopy for malign and benign disease. European Journal of Gynaecological Oncology. 2014. 35(1);52-55.
[1] Cicinelli E., Tinelli R., Loiudice L., Loiudice I., Quattromini P., Fusco A., et al.: “AlphaScope vs lens-based hysteroscope for office polypectomy without anesthesia: randomized controlled study“. J. Minim. Invasive Gynecol., 2011, 18, 796.
[2] Clark T.J.,Voit D., Gupta J.K., Hyde C, Song F., Khan KS.: “Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review“. JAMA, 2002, 288, 1610.
[3] Farquhar C., Ekeroma A., Furness S., Arroll B.: “A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women“. Acta Obstet. Gynecol. Scand., 2003, 82, 493.
[4] van Dongen H., de Kroon C.D., Jacobi C.E., Trimbos J.B., Jansen F. W.: “Diagnostic hysteroscopy in abnormal uterine bleeding: a sys-tematic review and meta-analysis“. BJOG, 2007, 114, 664.
[5] Marsh F.A., Rogerson L.J., Duffy S.R. “A randomised controlled trial comparing outpatient versus day case endometrial polypectomy“. BJOG, 2006, 113, 896.
[6] Clark T.J., Mahajan D., Sunder P., Gupta J.K.: “Hysteroscopic treatment of symptomatic submucous fibroids using a bipolar intrauterine system: a feasibility study“. Eur. J. Obstet. Gynecol. Reprod. Biol., 2002, 100, 237.
[7] Prasad P., Powell M.C.: “Prospective observational study of Thermablate Endometrial Ablation System as an outpatient procedure“. J. Minim. Invasive Gynecol., 2008, 15, 476.
[8] Sinha D., Kalathy V., Gupta J.K., Clark T.J.: “The feasibility, success and patient satisfaction associated with outpatient hysteroscopic sterilisation“. BJOG, 2007, 114, 676.
[9] Lau W.C., Ho R.Y., Tsang M.K., Yuen P.M.: “Patient’s acceptance of outpatient hysteroscopy“. Gynecol. Obstet. Invest., 1999, 47, 191.
[10] RCOG Green-top Guideline No. 59 Best Practice in Outpatient Hysteroscopy?
[11] Mencaglia L., Perino A., Hamou J.: “Hysteroscopy in perimenopausal and postmenopausal women with abnormal uterine bleeding“. J. Reprod. Med., 1987, 32, 577.
[12] Emanuel M.H., Verdel M.J., Wamsteker K., Lammes FB.: “A prospective comparison of transvaginal ultrasonography and diagnostic hysteroscopy in the evaluation of patients with abnormal uterine bleeding: clinical implications“. Am. J. Obstet. Gynecol., 1995, 172, 547.
[13] Metzger U., Bernard J.P., Camatte S., Lelièvre L., Robin F., Lefrère-Belda M.A, Lécuru F. Sono-guided endometrial biopsy: comparison with hysteroscopy biopsy. Sono-guided endometrial biopsy using the Bernard catheter had no impact on endometrial assessment by sonohysterography“. Gynecol. Obstet. Invest., 2004, 58, 26. Epub 2004 Mar 18.
[14] Kelekci S., Kaya E., Alan M., Alan Y., Bilge U., Mollamahmutoglu L.: “Comparison of transvaginal sonography, saline infusion sonography, and office hysteroscopy in reproductive-aged women with or without abnormal uterine bleeding“. Fertil. Steril., 2005, 84, 682.
[15] Fong K., Kung R., Lytwyn A., Trudeau M., Chapman W., Nugent P., et al.: “Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen“. Radiology, 2001, 220, 765.
[16] Dijkhuizen F.P., Brölmann H.A., Roumen R.M., Bastin F.H., Heintz A. P.: “Increase in risk of endometrial carcinoma following treatment of breast carcinoma with tamoxifen“. Ned. Tijdschr. Geneeskd., 1995, 139, 2393.
[17] Parsons A.K., Lense J.J.: “Sonohysterography for endometrial abnormalities: preliminary results“. J. Clin. Ultrasound, 1993, 21, 87.
[18] Dijkhuizen F.P., De Vries L.D., Mol B.W., Brölmann H.A., Peters H. M., Moret E., Heintz A.P.: “Comparison of transvaginal ultrasonography and saline infusion sonography for the detection of intracavitary abnormalities in premenopausal women“. Ultrasound Obstet. Gynecol., 2000, 15, 372.
[19] Williams C.D., Marshburn P.B.: “A prospective study of transvaginal hydrosonography in the evaluation of abnormal uterine bleeding“. Am. J. Obstet. Gynecol., 1998, 179, 292.
[20] Gull B., Karlsson B., Milsom I., Granberg S.: “Can ultrasound replace dilation and curettage? A longitudinal evaluation of postmenopausal bleeding and transvaginal sonographic measurement of the endometrium as predictors of endometrial cancer“. Am. J. Obstet. Gynecol., 2003, 188, 401.
[21] Maia H. Jr., Barbosa I.C., Farias J.P., Ladipo O.A., Coutinho E.M.: “Evaluation of the endometrial cavity during menopause“. Int. J. Gynaecol. Obstet., 1996, 52, 61.
[22] Smith-Bindman R., Kerlikowske K., Feldstein V.A., Subak L., Scheidler J., Segal M., et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA, 1998, 280, 1510.
[23] Clark T.J., Voit D., Gupta J.K., Hyde C., Song F., Khan K.S.: “Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review“. JAMA, 2002, 288, 1610.
[24] Gimpelson R.J.: “Panoramic hysteroscopy with directed biopsies vs. dilatation and curettage for accurate diagnosis“. J. Reprod. Med., 1984, 29, 575.
[25] Gimpelson R.J., Rappold H.O.: “A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases“. Am. J. Obstet. Gynecol., 1988, 158, 489.
Web of Science (WOS) (On Hold)
Journal Citation Reports/Science Edition
Google Scholar
JournalSeek
Top